Outcomes Of Relapsed/Refractory Patients With Idh1/2 Mutated Aml Treated With Non-Targeted Therapy: Results From The Ncri Aml TrialsR K Hills, R Gale,D C Linch, Huntly Bjp.,E Papaemmanuil,P Vyas,A K Burnett,N H RussellBLOOD（2018）引用 3|浏览37暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
